Deborah Waterhouse was appointed to GSK’s Corporate Executive Team on 8th January 2020. She became Chief Executive Officer of ViiV Healthcare on 1st April 2017. ViiV Healthcare is majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders.
Deborah joined GSK in 1996 and was most recently the Senior Vice President of Primary Ca...
Roles at ViiV Healthcare